Clinical Laserthermia Systems AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 4.46 million compared to SEK 4.3 million a year ago. Net loss was SEK 25.25 million compared to SEK 19.5 million a year ago.
Clinical Laserthermia Systems AB
Equities
CLS B
SE0022049920
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14 SEK | +3.58% | -6.32% | -49.28% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.28% | 99.15L | |
-18.63% | 25Cr | |
-31.35% | 8.2Cr |
- Stock Market
- Equities
- CLS B Stock
- News Clinical Laserthermia Systems AB
- Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023